BackOrchestra BioMed Holdings Overview

Orchestra BioMed Holdings Receivables

Track Orchestra BioMed Holdings's receivables ($51K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$51000.00
38.55% YoYΔ $-32000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Orchestra BioMed Holdings Receivables History

Loading

Orchestra BioMed Holdings vs. peers: Receivables Comparison

Loading

Orchestra BioMed Holdings Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orchestra BioMed Holdings (OBIO) FAQ

As of the most recent data (June 2026), OBIO shows a receivables of $51K. That compares with $83K in the prior-year period — down 38.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OBIO's receivables is now $51K (was $83K) — a 38.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orchestra BioMed Holdings is outperforming or lagging.

Tracking OBIO's receivables over time shows whether Orchestra BioMed Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $51K That compares with $83K in the prior-year period — down 38.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Orchestra BioMed Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $51K) with ownership activity and broader fundamentals.